Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Not yet recruiting 2Unknown 1

Sponsor Class

OTHER_GOV 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 57Carcinoma, Hepatocellular 45Colorectal Neoplasms 18Esophageal Squamous Cell Carcinoma 10Cholangiocarcinoma 10Esophageal Neoplasms 9Advanced Gastric Cancer 9Biliary Tract Neoplasms 8Pancreatic Neoplasms 6Liver Neoplasms 5Neoplasms 3Neoplasm Metastasis 3Gastrointestinal Neoplasms 3Gastric Adenocarcinoma 3Digestive System Neoplasms 3Recurrence 2Metastatic Gastric Adenocarcinoma 2Locally Advanced Gastric Cancer 2Gastrointestinal Stromal Tumors 2Advanced Esophagus Cancer 2Uterine Cervical Neoplasms 1Stomach Diseases 1Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence 1Peritoneal Metastases From Gastric Cancer 1Ovarian Neoplasms 1Locally Advanced or Metastatic Gastric Adenocarcinoma 1Intestinal Neoplasms 1Immunotherapy Gastrict Cancer 1Immunotherapy 1Hepatic Metastasis of Colorectal Cancer 1

Interventions

Gastrectomy 4apatinib 3Taxes 3S 1 (combination) 3Oxaliplatin 3Cisplatin 3sintilimab 2Paclitaxel 2Hyperthermic Intraperitoneal Chemotherapy 2Drug Therapy 2Docetaxel 2Albumin-Bound Paclitaxel 2trifluridine tipiracil drug combination 1trastuzumab deruxtecan 1tipiracil 1taxane 1pembrolizumab 1durvalumab 1disitamab vedotin 1cabozantinib 1andecaliximab 1XELOX 1Trifluridine 1Tegafur 1Tadalafil 1SHR-1701 1Resistance Training 1Radiotherapy 1Platinum 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Gastric Adenocarcinoma × apatinib × Gastrointestinal × Clear all
NCT07610629 2026-05-28

RA-A-NP

Henan Cancer Hospital

Phase 2 Not yet recruiting
50 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT07464756 2026-03-11

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Not yet recruiting
80 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT04121039 2019-10-09

Study of the Apatinib Combine With POF Versus POF in Gastric Cancer

Fujian Cancer Hospital

Phase 2 Unknown
116 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡